SCHEMBL7744579

SCHEMBL7744579

N#CCCPCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225856 0.72
SCHEMBL7586060 0.67
SCHEMBL27770285 0.67
SCHEMBL56391 0.64
SCHEMBL16037462 0.64 ALDH1A1 (1.00)
SCHEMBL18460285 0.64
SCHEMBL2683512 0.60
SCHEMBL30321467 0.60
Lithium SCHEMBL29763173 0.60
Lithium SCHEMBL29833770 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113423842-A Probes having octamine or octamine derivatives bound thereto and uses thereof 柏业公司 2021-09-21 CN disclosed
US-RE45907-E1 Functionalized stilbene derivatives as improved vascular targeting agents OXIGENE, INC. (US) 2016-03-01 US disclosed
US-RE45720-E1 Functionalized stilbene derivatives as improved vascular targeting agents OXIGENE, INC. (US) 2015-10-06 US disclosed
US-7384925-B2 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) OXIGENE, INC. (US) 2008-06-10 US disclosed
CN-1501961-A Thermoplastic elastomer composition and molded object thereof ס�ѻ�ѧ��ҵ��ʽ���� 2004-06-02 CN disclosed
EP-0979233-A4 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO L L C (US) 2001-03-21 EP disclosed
EP-0979233-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 2000-02-16 EP disclosed
WO-1998047910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO LLC (US) 1998-10-29 WO disclosed